Literature DB >> 21954119

Myocardial T1 mapping with MRI: comparison of look-locker and MOLLI sequences.

Marcelo Souto Nacif1, Evrim B Turkbey, Neville Gai, Saman Nazarian, Rob J van der Geest, Radwa A Noureldin, Christopher T Sibley, Martin Ugander, Songtao Liu, Andrew E Arai, João A C Lima, David A Bluemke.   

Abstract

PURPOSE: To evaluate the relationship between "Look-Locker" (LL) and modified Look-Locker Inversion recovery (MOLLI) approaches for T1 mapping of the myocardium.
MATERIALS AND METHODS: A total of 168 myocardial T1 maps using MOLLI and 165 maps using LL were obtained in human subjects at 1.5 Tesla. The T1 values of the myocardium were calculated before and at five time points after gadolinium administration. All time and heart rate normalizations were done. The T1 values obtained were compared to determine the absolute and bias agreement.
RESULTS: The precontrast global T1 values were similar when measured by the LL and by MOLLI technique (mean, 1004.9 ms ± 120.3 versus 1034.1 ms ± 53.1, respectively, P = 0.26). Postcontrast myocardial T1 time from LL was significantly longer than MOLLI from 5 to 25 min (mean difference, LL - MOLLI was +61.8 ± 46.4 ms, P < 0.001). No significant differences in T1 values were noted between long and short axis measurements for either MOLLI or LL.
CONCLUSION: Postcontrast LL and MOLLI showed very good agreement, although LL values are higher than MOLLI. Precontrast T1 values showed good agreement, however LL has greater limits of agreement. Short and long axis planes can reliably assess T1 values.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21954119      PMCID: PMC3221792          DOI: 10.1002/jmri.22753

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  20 in total

1.  Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart.

Authors:  Daniel R Messroghli; Andreas Greiser; Mirko Fröhlich; Rainer Dietz; Jeanette Schulz-Menger
Journal:  J Magn Reson Imaging       Date:  2007-10       Impact factor: 4.813

2.  An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging.

Authors:  Daniel R Messroghli; Andre Rudolph; Hassan Abdel-Aty; Ralf Wassmuth; Titus Kühne; Rainer Dietz; Jeanette Schulz-Menger
Journal:  BMC Med Imaging       Date:  2010-07-30       Impact factor: 1.930

3.  Repeatability of T1-quantification in dGEMRIC for three different acquisition techniques: two-dimensional inversion recovery, three-dimensional look locker, and three-dimensional variable flip angle.

Authors:  Carl Siversson; Carl-Johan Tiderius; Paul Neuman; Leif Dahlberg; Jonas Svensson
Journal:  J Magn Reson Imaging       Date:  2010-05       Impact factor: 4.813

4.  Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

Authors:  Andrew S Flett; Martin P Hayward; Michael T Ashworth; Michael S Hansen; Andrew M Taylor; Perry M Elliott; Christopher McGregor; James C Moon
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

5.  The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Evrim B Turkbey; Robyn L McClelland; Richard A Kronmal; Gregory L Burke; Diane E Bild; Russell P Tracy; Andrew E Arai; João A C Lima; David A Bluemke
Journal:  JACC Cardiovasc Imaging       Date:  2010-03

6.  Rapid T1 quantification based on 3D phase sensitive inversion recovery.

Authors:  Marcel J B Warntjes; Johan Kihlberg; Jan Engvall
Journal:  BMC Med Imaging       Date:  2010-08-17       Impact factor: 1.930

7.  Contrast-enhanced myocardial T1-weighted scout (Look-Locker) imaging for the detection of myocardial damages in hypertrophic cardiomyopathy.

Authors:  Yasuo Amano; Morimasa Takayama; Shinichiro Kumita
Journal:  J Magn Reson Imaging       Date:  2009-10       Impact factor: 4.813

8.  Shorter difference between myocardium and blood optimal inversion time suggests diffuse fibrosis in dilated cardiomyopathy.

Authors:  Yuchi Han; Dana C Peters; Basem Dokhan; Warren J Manning
Journal:  J Magn Reson Imaging       Date:  2009-11       Impact factor: 4.813

9.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

Authors:  Leah Iles; Heinz Pfluger; Arintaya Phrommintikul; Joshi Cherayath; Pelin Aksit; Sandeep N Gupta; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

10.  Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction.

Authors:  Daniel R Messroghli; Kevin Walters; Sven Plein; Patrick Sparrow; Matthias G Friedrich; John P Ridgway; Mohan U Sivananthan
Journal:  Magn Reson Med       Date:  2007-07       Impact factor: 3.737

View more
  50 in total

Review 1.  Imaging sequences in cardiovascular magnetic resonance: current role, evolving applications, and technical challenges.

Authors:  El-Sayed H Ibrahim
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-25       Impact factor: 2.357

2.  Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.

Authors:  Gaetano Nucifora; Daniele Muser; Pasquale Gianfagna; Giorgio Morocutti; Alessandro Proclemer
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-26       Impact factor: 2.357

3.  Quantitative inversion time prescription for myocardial late gadolinium enhancement using T1-mapping-based synthetic inversion recovery imaging: reducing subjectivity in the estimation of inversion time.

Authors:  Sebastian Gassenmaier; Rob J van der Geest; U Joseph Schoepf; Pal Suranyi; Wolfgang G Rehwald; Carlo N De Cecco; Domenico Mastrodicasa; Moritz H Albrecht; Domenico De Santis; Virginia W Lesslie; Balazs Ruzsics; Akos Varga-Szemes
Journal:  Int J Cardiovasc Imaging       Date:  2018-01-05       Impact factor: 2.357

4.  Novel cardiac magnetic resonance biomarkers: native T1 and extracellular volume myocardial mapping.

Authors:  Paola Maria Cannaò; Luisa Altabella; Marcello Petrini; Marco Alì; Francesco Secchi; Francesco Sardanelli
Journal:  Eur Heart J Suppl       Date:  2016-04-29       Impact factor: 1.803

Review 5.  Cardiac T(1) imaging.

Authors:  Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Top Magn Reson Imaging       Date:  2014-02

6.  Myocardial scar identification based on analysis of Look-Locker and 3D late gadolinium enhanced MRI.

Authors:  Qian Tao; Hildo J Lamb; Katja Zeppenfeld; Rob J van der Geest
Journal:  Int J Cardiovasc Imaging       Date:  2014-03-19       Impact factor: 2.357

7.  Influence of spatial resolution and contrast agent dosage on myocardial T1 relaxation times.

Authors:  Edyta Blaszczyk; Agnieszka Töpper; Luisa Schmacht; Felix Wanke; Andreas Greiser; Jeanette Schulz-Menger; Florian von Knobelsdorff-Brenkenhoff
Journal:  MAGMA       Date:  2016-08-20       Impact factor: 2.310

8.  T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.

Authors:  Christopher T Sibley; Radwa A Noureldin; Neville Gai; Marcelo Souto Nacif; Songtao Liu; Evrim B Turkbey; James O Mudd; Rob J van der Geest; João A C Lima; Marc K Halushka; David A Bluemke
Journal:  Radiology       Date:  2012-10-22       Impact factor: 11.105

9.  Myocardial T1 Measurement Predicts Beneficial LV Remodeling After Long-Term Heart Failure Therapy.

Authors:  William S Bradham; Susan P Bell; Douglas W Adkisson; Holly M Smith; Frank E Harrell; Mark A Lawson; Henry Ooi; Douglas B Sawyer; Marvin W Kronenberg
Journal:  J Card Fail       Date:  2016-12-08       Impact factor: 5.712

10.  Temporally resolved parametric assessment of Z-magnetization recovery (TOPAZ): Dynamic myocardial T1 mapping using a cine steady-state look-locker approach.

Authors:  Sebastian Weingärtner; Chetan Shenoy; Benedikt Rieger; Lothar R Schad; Jeanette Schulz-Menger; Mehmet Akçakaya
Journal:  Magn Reson Med       Date:  2017-08-30       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.